New Delhi: Complying with the National Medical Commission PG Medical Regulations 2021, the Bihar-based Aryabhatta Knowledge University has recently decided that all the answer scripts of PG medical courses in the State Institutes would now be evaluated doubly.
The confirmation regarding this came from the Dean of the Medicine Faculty of the University Dr Rajiv Ranjan Prasad, reports TOI.
Referring to the NMC rules, Dr. Prasad confirmed that now all the PG medical answer scripts shall be sent by the University to two examiners for separate evaluation and for a specific paper, the average of the total marks awarded by the two examiners shall be considered for calculating the results.
Medical Dialogues had last year reported that the Apex Medical Education Regulatory body, NMC had introduced Post Graduate Medical Education Regulations 2021, with an aim to make the medical academia more cogent.
Also Read: National Medical Commission releases new draft Postgraduate Medical Education Regulations 2021, invites comments
Section 18.2 of the Postgraduate Medical Education Regulations 2021 states, "All the answer scripts shall be subjected for two valuations by the concerned University. The average of the total marks awarded by the two valuators for the paper, which is rounded off to the nearest value, shall be considered for computation of the results. All the answer scripts, where the difference between two valuations is 15% and more of the total marks prescribed for the paper, shall be subjected to third valuation. The average of the best two total marks, awarded by the three evaluators for the paper, rounded off to the nearest value, shall be considered for final computation of the results."
As per the latest media report by the
Times of India, now the
Aryabhatta Knowledge University, which has the charge of regulating all the government and private medical institutes in Bihar, has decided to comply with the NMC rules regarding the evaluation of the answer scripts. Therefore, now all the answer scripts of PG medical courses in the Bihar-based institutes would be subjected to double evaluation.For computing the results, the average of total marks given by two evaluators shall be taken into consideration and it shall be rounded off to the nearest value, informed Dr. Prasad.
He further informed TOI, "All the answer scripts, where the difference between two valuations is 15% and more of the total marks prescribed for the paper, shall be subjected to third valuation. The average of the best two total marks, awarded by the three evaluators for the paper, rounded off to the nearest value, shall be considered for final computation of the results."
"The maximum number of candidates to be examined in clinical/practical and oral on any day shall not exceed eight for MD/MS degree and three for DM/MCh examinations. The university shall conduct not more than two examinations in a year," he added.
Besides, he clarified that after computing the marks and declaration of the results, no authority shall permit revaluation under any circumstances. Apart from this, the University shall also develop a platform for bar-coded digital valuation. Referring to the rules regarding Examiners,
section 18.1 of the PG Medical Education Regulations 2021 states, "1. All the Post Graduate Examiners in Broad and Super Specialties shall have three years' experience as recognized Post Graduate Guides in the concerned subject. 2. For all Post Graduate Examination, the minimum number of Examiners shall be four, out of which two shall be External Examiners, who shall be invited from other universities from outside the State. 3. An examiner shall ordinarily be not appointed for more than two consecutive regular examinations for the same Institution."Also Read: NMC to relook at draft PG regulations, allow improvement of NEXT score every year
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd